
Imperative Care is speeding new answers to stroke by developing a portfolio of innovative solutions to address the vast and urgent unmet needs in stroke care. The company is singularly dedicated to improving the way stroke is treated by advancing medical technology, equipping healthcare providers to evolve best practices and elevate the standard of care for stroke patients.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 12/10/19 | $85,000,000 | Series C |
3H Health Investment Ally Bridge Group ![]() Ascension Ventures Bain Capital ![]() Delos Capital Fund LP Incept Rock Springs Capital | undisclosed |
| 03/18/26 | $100,000,000 | Convertible Note |
Ally Bridge Group Bain Capital Life Sciences Brown Advisory Catalio Capital Management Elevage Medical Technologies ![]() Longaeva Partners LP Perceptive Advisors ![]() | undisclosed |